Gary Frey

935 total citations
9 papers, 738 citations indexed

About

Gary Frey is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Gary Frey has authored 9 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Virology, 4 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Gary Frey's work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Gary Frey is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Gary Frey collaborates with scholars based in United States and Poland. Gary Frey's co-authors include Bing Chen, Sophia Rits‐Volloch, Hanqin Peng, Stephen C. Harrison, Jia Chen, Marco J. Morelli, Yifan Cheng, Michael S. Seaman, Robert T. Schooley and James J. Chou and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The EMBO Journal.

In The Last Decade

Gary Frey

9 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Frey United States 9 455 315 229 209 187 9 738
Erik Vogan United States 10 408 0.9× 409 1.3× 207 0.9× 228 1.1× 126 0.7× 11 835
James M. Kovacs United States 16 318 0.7× 445 1.4× 142 0.6× 287 1.4× 140 0.7× 22 914
Craig S. Pace United States 13 513 1.1× 491 1.6× 352 1.5× 242 1.2× 160 0.9× 24 1.1k
Janet Lineberger United States 13 454 1.0× 280 0.9× 237 1.0× 273 1.3× 78 0.4× 15 824
Renee Danzeisen United States 11 406 0.9× 286 0.9× 241 1.1× 198 0.9× 137 0.7× 12 640
Yumiko Adachi United States 8 388 0.9× 465 1.5× 155 0.7× 300 1.4× 297 1.6× 9 815
Gemma E. Seabright United Kingdom 12 313 0.7× 451 1.4× 351 1.5× 201 1.0× 200 1.1× 15 859
Heidi Jonckheere Belgium 11 308 0.7× 277 0.9× 368 1.6× 103 0.5× 177 0.9× 13 673
Amy M. Princiotto United States 18 878 1.9× 479 1.5× 658 2.9× 318 1.5× 215 1.1× 21 1.3k
Malcolm Macartney United Kingdom 9 663 1.5× 284 0.9× 523 2.3× 217 1.0× 85 0.5× 19 1.1k

Countries citing papers authored by Gary Frey

Since Specialization
Citations

This map shows the geographic impact of Gary Frey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Frey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Frey more than expected).

Fields of papers citing papers by Gary Frey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Frey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Frey. The network helps show where Gary Frey may publish in the future.

Co-authorship network of co-authors of Gary Frey

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Frey. A scholar is included among the top collaborators of Gary Frey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Frey. Gary Frey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Frey, Gary, et al.. (2021). Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease. ACS Infectious Diseases. 7(9). 2591–2595. 52 indexed citations
2.
Xiao, Tianshu, Gary Frey, Qingshan Fu, et al.. (2020). HIV-1 fusion inhibitors targeting the membrane-proximal external region of Env spikes. Nature Chemical Biology. 16(5). 529–537. 29 indexed citations
3.
Dev, Jyoti, Donghyun Park, Qingshan Fu, et al.. (2016). Structural basis for membrane anchoring of HIV-1 envelope spike. Science. 353(6295). 172–175. 141 indexed citations
4.
Chen, Jia, Gary Frey, Hanqin Peng, et al.. (2013). Mechanism of HIV-1 Neutralization by Antibodies Targeting a Membrane-Proximal Region of gp41. Journal of Virology. 88(2). 1249–1258. 81 indexed citations
5.
Frey, Gary, Jia Chen, Sophia Rits‐Volloch, et al.. (2010). Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies. Nature Structural & Molecular Biology. 17(12). 1486–1491. 65 indexed citations
6.
Frey, Gary, Hanqin Peng, Sophia Rits‐Volloch, et al.. (2008). A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies. Proceedings of the National Academy of Sciences. 105(10). 3739–3744. 189 indexed citations
7.
Rits‐Volloch, Sophia, Gary Frey, Stephen C. Harrison, & Bing Chen. (2006). Restraining the conformation of HIV‐1 gp120 by removing a flexible loop. The EMBO Journal. 25(20). 5026–5035. 22 indexed citations
8.
Frey, Gary, et al.. (2006). Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion. Proceedings of the National Academy of Sciences. 103(38). 13938–13943. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026